Principal Investigator
Jonathan Trent
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20201368
Clinical Trial Summary
ctDNA-Guided Sunitinib And Regorafenib Therapy for Gastrointestinal Stromal Tumor (GIST)
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Bone and Soft Tissue Cancers
Contact Information
Phone Number
305-243-2647